| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 2 |
| GO:0005849 | mRNA cleavage factor complex | 3 | 2 |
| GO:0032991 | protein-containing complex | 1 | 2 |
| GO:0140513 | nuclear protein-containing complex | 2 | 2 |
Related structures:
AlphaFold database: Q4Q563
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
| GO:0006379 | mRNA cleavage | 7 | 2 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016070 | RNA metabolic process | 5 | 2 |
| GO:0016071 | mRNA metabolic process | 6 | 2 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
| GO:0043170 | macromolecule metabolic process | 3 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0046483 | heterocycle metabolic process | 3 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:0090304 | nucleic acid metabolic process | 4 | 2 |
| GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 2 |
| GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 2 |
| GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 2 |
| GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 2 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 10 |
| GO:0003723 | RNA binding | 4 | 10 |
| GO:0003729 | mRNA binding | 5 | 2 |
| GO:0005488 | binding | 1 | 10 |
| GO:0097159 | organic cyclic compound binding | 2 | 10 |
| GO:1901363 | heterocyclic compound binding | 2 | 10 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.768 |
| CLV_NRD_NRD_1 | 256 | 258 | PF00675 | 0.716 |
| CLV_NRD_NRD_1 | 316 | 318 | PF00675 | 0.814 |
| CLV_NRD_NRD_1 | 386 | 388 | PF00675 | 0.604 |
| CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.343 |
| CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.662 |
| CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.612 |
| CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.642 |
| CLV_PCSK_KEX2_1 | 318 | 320 | PF00082 | 0.808 |
| CLV_PCSK_KEX2_1 | 395 | 397 | PF00082 | 0.572 |
| CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.331 |
| CLV_PCSK_PC1ET2_1 | 112 | 114 | PF00082 | 0.662 |
| CLV_PCSK_PC1ET2_1 | 220 | 222 | PF00082 | 0.612 |
| CLV_PCSK_PC1ET2_1 | 318 | 320 | PF00082 | 0.808 |
| CLV_PCSK_PC1ET2_1 | 395 | 397 | PF00082 | 0.613 |
| CLV_PCSK_PC7_1 | 314 | 320 | PF00082 | 0.775 |
| CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.532 |
| CLV_PCSK_SKI1_1 | 298 | 302 | PF00082 | 0.708 |
| CLV_PCSK_SKI1_1 | 369 | 373 | PF00082 | 0.526 |
| CLV_PCSK_SKI1_1 | 395 | 399 | PF00082 | 0.612 |
| DEG_APCC_DBOX_1 | 241 | 249 | PF00400 | 0.608 |
| DEG_APCC_DBOX_1 | 386 | 394 | PF00400 | 0.523 |
| DEG_COP1_1 | 374 | 384 | PF00400 | 0.637 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.705 |
| DEG_SCF_FBW7_1 | 282 | 288 | PF00400 | 0.728 |
| DEG_SCF_FBW7_2 | 343 | 349 | PF00400 | 0.733 |
| DEG_SPOP_SBC_1 | 84 | 88 | PF00917 | 0.678 |
| DOC_CKS1_1 | 273 | 278 | PF01111 | 0.743 |
| DOC_CKS1_1 | 282 | 287 | PF01111 | 0.699 |
| DOC_CKS1_1 | 343 | 348 | PF01111 | 0.742 |
| DOC_CYCLIN_RxL_1 | 206 | 214 | PF00134 | 0.483 |
| DOC_CYCLIN_RxL_1 | 392 | 401 | PF00134 | 0.616 |
| DOC_CYCLIN_yCln2_LP_2 | 265 | 271 | PF00134 | 0.674 |
| DOC_CYCLIN_yCln2_LP_2 | 89 | 95 | PF00134 | 0.751 |
| DOC_MAPK_gen_1 | 165 | 173 | PF00069 | 0.616 |
| DOC_PP1_RVXF_1 | 142 | 148 | PF00149 | 0.535 |
| DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.741 |
| DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.625 |
| DOC_USP7_MATH_1 | 143 | 147 | PF00917 | 0.750 |
| DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.569 |
| DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.538 |
| DOC_USP7_MATH_1 | 252 | 256 | PF00917 | 0.633 |
| DOC_USP7_MATH_1 | 274 | 278 | PF00917 | 0.778 |
| DOC_USP7_MATH_1 | 293 | 297 | PF00917 | 0.531 |
| DOC_USP7_MATH_1 | 307 | 311 | PF00917 | 0.700 |
| DOC_USP7_MATH_1 | 322 | 326 | PF00917 | 0.529 |
| DOC_USP7_MATH_1 | 331 | 335 | PF00917 | 0.783 |
| DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.565 |
| DOC_USP7_UBL2_3 | 298 | 302 | PF12436 | 0.791 |
| DOC_WW_Pin1_4 | 272 | 277 | PF00397 | 0.792 |
| DOC_WW_Pin1_4 | 281 | 286 | PF00397 | 0.641 |
| DOC_WW_Pin1_4 | 342 | 347 | PF00397 | 0.759 |
| LIG_14-3-3_CanoR_1 | 144 | 148 | PF00244 | 0.533 |
| LIG_14-3-3_CanoR_1 | 175 | 180 | PF00244 | 0.618 |
| LIG_14-3-3_CanoR_1 | 194 | 202 | PF00244 | 0.343 |
| LIG_14-3-3_CanoR_1 | 369 | 374 | PF00244 | 0.529 |
| LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.667 |
| LIG_14-3-3_CanoR_1 | 85 | 90 | PF00244 | 0.714 |
| LIG_BRCT_BRCA1_1 | 8 | 12 | PF00533 | 0.464 |
| LIG_FHA_1 | 176 | 182 | PF00498 | 0.535 |
| LIG_FHA_1 | 336 | 342 | PF00498 | 0.802 |
| LIG_FHA_2 | 346 | 352 | PF00498 | 0.620 |
| LIG_FHA_2 | 59 | 65 | PF00498 | 0.561 |
| LIG_FHA_2 | 71 | 77 | PF00498 | 0.561 |
| LIG_LIR_Gen_1 | 199 | 210 | PF02991 | 0.473 |
| LIG_LIR_Gen_1 | 37 | 45 | PF02991 | 0.537 |
| LIG_LIR_Gen_1 | 377 | 385 | PF02991 | 0.592 |
| LIG_LIR_Nem_3 | 10 | 16 | PF02991 | 0.437 |
| LIG_LIR_Nem_3 | 116 | 121 | PF02991 | 0.601 |
| LIG_LIR_Nem_3 | 170 | 176 | PF02991 | 0.639 |
| LIG_LIR_Nem_3 | 199 | 205 | PF02991 | 0.467 |
| LIG_LIR_Nem_3 | 37 | 41 | PF02991 | 0.470 |
| LIG_LIR_Nem_3 | 377 | 381 | PF02991 | 0.584 |
| LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.490 |
| LIG_LYPXL_yS_3 | 118 | 121 | PF13949 | 0.565 |
| LIG_MLH1_MIPbox_1 | 9 | 13 | PF16413 | 0.440 |
| LIG_SH2_CRK | 51 | 55 | PF00017 | 0.452 |
| LIG_SH2_NCK_1 | 202 | 206 | PF00017 | 0.469 |
| LIG_SH2_STAT5 | 177 | 180 | PF00017 | 0.475 |
| LIG_SH3_1 | 111 | 117 | PF00018 | 0.723 |
| LIG_SH3_3 | 111 | 117 | PF00018 | 0.774 |
| LIG_SH3_3 | 124 | 130 | PF00018 | 0.704 |
| LIG_SH3_3 | 265 | 271 | PF00018 | 0.791 |
| LIG_SH3_3 | 286 | 292 | PF00018 | 0.704 |
| LIG_SH3_3 | 340 | 346 | PF00018 | 0.757 |
| LIG_SH3_3 | 378 | 384 | PF00018 | 0.670 |
| LIG_SH3_4 | 298 | 305 | PF00018 | 0.615 |
| LIG_SUMO_SIM_anti_2 | 14 | 21 | PF11976 | 0.444 |
| LIG_SUMO_SIM_anti_2 | 353 | 361 | PF11976 | 0.548 |
| LIG_SUMO_SIM_par_1 | 209 | 214 | PF11976 | 0.488 |
| LIG_TRAF2_1 | 197 | 200 | PF00917 | 0.559 |
| LIG_TRAF2_1 | 61 | 64 | PF00917 | 0.490 |
| LIG_WRC_WIRS_1 | 35 | 40 | PF05994 | 0.543 |
| MOD_CK1_1 | 120 | 126 | PF00069 | 0.796 |
| MOD_CK1_1 | 277 | 283 | PF00069 | 0.807 |
| MOD_CK1_1 | 336 | 342 | PF00069 | 0.707 |
| MOD_CK1_1 | 6 | 12 | PF00069 | 0.514 |
| MOD_CK2_1 | 200 | 206 | PF00069 | 0.600 |
| MOD_CK2_1 | 345 | 351 | PF00069 | 0.634 |
| MOD_CK2_1 | 358 | 364 | PF00069 | 0.546 |
| MOD_CK2_1 | 58 | 64 | PF00069 | 0.490 |
| MOD_CK2_1 | 70 | 76 | PF00069 | 0.490 |
| MOD_DYRK1A_RPxSP_1 | 342 | 346 | PF00069 | 0.549 |
| MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.756 |
| MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.581 |
| MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.591 |
| MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.554 |
| MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.587 |
| MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.764 |
| MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.769 |
| MOD_GlcNHglycan | 324 | 327 | PF01048 | 0.694 |
| MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.718 |
| MOD_GlcNHglycan | 373 | 376 | PF01048 | 0.618 |
| MOD_GSK3_1 | 117 | 124 | PF00069 | 0.796 |
| MOD_GSK3_1 | 155 | 162 | PF00069 | 0.713 |
| MOD_GSK3_1 | 277 | 284 | PF00069 | 0.763 |
| MOD_GSK3_1 | 3 | 10 | PF00069 | 0.551 |
| MOD_GSK3_1 | 303 | 310 | PF00069 | 0.802 |
| MOD_GSK3_1 | 318 | 325 | PF00069 | 0.673 |
| MOD_GSK3_1 | 331 | 338 | PF00069 | 0.668 |
| MOD_GSK3_1 | 341 | 348 | PF00069 | 0.618 |
| MOD_GSK3_1 | 79 | 86 | PF00069 | 0.539 |
| MOD_N-GLC_1 | 121 | 126 | PF02516 | 0.801 |
| MOD_NEK2_1 | 121 | 126 | PF00069 | 0.564 |
| MOD_NEK2_1 | 358 | 363 | PF00069 | 0.676 |
| MOD_NEK2_1 | 371 | 376 | PF00069 | 0.608 |
| MOD_NEK2_1 | 69 | 74 | PF00069 | 0.500 |
| MOD_NEK2_1 | 79 | 84 | PF00069 | 0.481 |
| MOD_NEK2_2 | 293 | 298 | PF00069 | 0.639 |
| MOD_PIKK_1 | 155 | 161 | PF00454 | 0.662 |
| MOD_PIKK_1 | 274 | 280 | PF00454 | 0.664 |
| MOD_PIKK_1 | 333 | 339 | PF00454 | 0.732 |
| MOD_PKA_1 | 318 | 324 | PF00069 | 0.770 |
| MOD_PKA_2 | 143 | 149 | PF00069 | 0.532 |
| MOD_PKA_2 | 167 | 173 | PF00069 | 0.596 |
| MOD_PKA_2 | 3 | 9 | PF00069 | 0.627 |
| MOD_PKA_2 | 318 | 324 | PF00069 | 0.750 |
| MOD_PKA_2 | 341 | 347 | PF00069 | 0.534 |
| MOD_PKA_2 | 79 | 85 | PF00069 | 0.596 |
| MOD_Plk_1 | 105 | 111 | PF00069 | 0.728 |
| MOD_Plk_2-3 | 70 | 76 | PF00069 | 0.591 |
| MOD_Plk_4 | 14 | 20 | PF00069 | 0.369 |
| MOD_Plk_4 | 184 | 190 | PF00069 | 0.533 |
| MOD_Plk_4 | 336 | 342 | PF00069 | 0.802 |
| MOD_Plk_4 | 7 | 13 | PF00069 | 0.461 |
| MOD_ProDKin_1 | 272 | 278 | PF00069 | 0.791 |
| MOD_ProDKin_1 | 281 | 287 | PF00069 | 0.643 |
| MOD_ProDKin_1 | 342 | 348 | PF00069 | 0.748 |
| MOD_SUMO_for_1 | 300 | 303 | PF00179 | 0.732 |
| MOD_SUMO_rev_2 | 214 | 222 | PF00179 | 0.636 |
| TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.490 |
| TRG_DiLeu_BaEn_1 | 354 | 359 | PF01217 | 0.640 |
| TRG_DiLeu_BaLyEn_6 | 393 | 398 | PF01217 | 0.469 |
| TRG_DiLeu_LyEn_5 | 218 | 223 | PF01217 | 0.593 |
| TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.600 |
| TRG_ENDOCYTIC_2 | 202 | 205 | PF00928 | 0.464 |
| TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.471 |
| TRG_ER_diArg_1 | 110 | 113 | PF00400 | 0.768 |
| TRG_ER_diArg_1 | 66 | 68 | PF00400 | 0.561 |
| TRG_NES_CRM1_1 | 389 | 403 | PF08389 | 0.394 |
| TRG_NLS_MonoExtC_3 | 110 | 115 | PF00514 | 0.807 |
| TRG_Pf-PMV_PEXEL_1 | 209 | 214 | PF00026 | 0.488 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I4N7 | Leptomonas seymouri | 57% | 100% |
| A0A1X0NU71 | Trypanosomatidae | 31% | 100% |
| A0A3Q8ITD1 | Leishmania donovani | 94% | 100% |
| A0A3R7KNF2 | Trypanosoma rangeli | 34% | 100% |
| A4HKK3 | Leishmania braziliensis | 83% | 100% |
| A4I835 | Leishmania infantum | 94% | 100% |
| E9B2Z3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
| V5BKQ1 | Trypanosoma cruzi | 36% | 100% |